Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14001 - 14025 of 14497 in total
UK-390,957 has been used in trials studying the treatment of Ejaculation.
Investigational
Talinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Investigational
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational
Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
Investigational
LY2886721 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
Get 73 has been investigated for the treatment of Alcohol Dependence.
Investigational
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
Displaying drugs 14001 - 14025 of 14497 in total